BioCentury | May 6, 2013
Finance

Keep it small

...firm had only invested in four diagnostic plays since 2000 - including On-Q-ity Inc. , Aureon Biosciences Inc....
BioCentury | Oct 10, 2011
Company News

Exosome Diagnostics management update

...York, N.Y. Business: Diagnostic, Cancer Hired: Michael Donovan as CMO, formerly chief scientific officer of Aureon Biosciences Inc....
BioCentury | Oct 5, 2011
Company News

Exosome expands management team

...Michael Donovan as CMO and David Okrongly as COO. Donovan is the former CSO of Aureon BioSciences Inc....
BioCentury | Dec 7, 2009
Finance

Ebb & Flow

...The Channel Group as a partner. He was president and CEO of tissue analysis company Aureon...
BioCentury | Aug 31, 2009
Company News

Aureon Laboratories Inc. management update

Aureon Laboratories Inc. , Yonkers, N.Y. Business: Diagnostic, Pharmacogenetics Promoted: Robert Shovlin to CEO from COO while remaining president; he replaces Vijay Aggarwal, who will remain a director WIR Staff Diagnostic...
BioCentury | Jul 24, 2008
Tools & Techniques

Imaging Prostate Cancer Metastasis

...gene in the presence of the prodrug ganciclovir. 3 Jason Alter, director of marketing at Aureon...
...for these patients. Although a ways away, imaging coupled with gene therapy has exciting potential." Aureon...
...recognizes PSMA, to image the extent and spread of prostate cancer. Companies and Institutions Mentioned Aureon...
BioCentury | Jun 16, 2008
Company News

Aureon Laboratories Inc., University of Texas M. D. Anderson Cancer Center deal

...discover biomarkers associated with disease progression and overall survival in non-small cell lung cancer (NSCLC). Aureon...
...from NSCLC patients for histological and molecular analysis. Further terms were not disclosed. Last month, Aureon...
...prostate cancer progression and disease recurrence at the time of diagnosis (see BioCentury, May 26). Aureon...
BioCentury | May 26, 2008
Company News

Aureon Biosciences Corp. sales and marketing update

...Px+ test to predict prostate cancer progression and disease recurrence at the time of diagnosis. Aureon...
BioCentury | Mar 24, 2008
Company News

Aureon Laboratories Inc. management update

Aureon Laboratories Inc. , Yonkers, N.Y. Business: Diagnostic, Pharmacogenetics Hired: Ana Stanic as CFO, formerly EVP and CFO of Omrix Biopharmaceuticals Inc. WIR Staff Diagnostic...
BioCentury | Jan 28, 2008
Company News

Aureon Laboratories Inc., Pfizer deal

...The companies will use Aureon's integrated systems pathology approach to establish quantitative biometrics for assessing prostate...
...work is an extension of a 2007 collaboration that demonstrated the technical feasibility of using Aureon's...
...the cellular distribution of cytokines in prosatectomy samples from patients treated with ADT from Pfizer. Aureon...
Items per page:
1 - 10 of 19
BioCentury | May 6, 2013
Finance

Keep it small

...firm had only invested in four diagnostic plays since 2000 - including On-Q-ity Inc. , Aureon Biosciences Inc....
BioCentury | Oct 10, 2011
Company News

Exosome Diagnostics management update

...York, N.Y. Business: Diagnostic, Cancer Hired: Michael Donovan as CMO, formerly chief scientific officer of Aureon Biosciences Inc....
BioCentury | Oct 5, 2011
Company News

Exosome expands management team

...Michael Donovan as CMO and David Okrongly as COO. Donovan is the former CSO of Aureon BioSciences Inc....
BioCentury | Dec 7, 2009
Finance

Ebb & Flow

...The Channel Group as a partner. He was president and CEO of tissue analysis company Aureon...
BioCentury | Aug 31, 2009
Company News

Aureon Laboratories Inc. management update

Aureon Laboratories Inc. , Yonkers, N.Y. Business: Diagnostic, Pharmacogenetics Promoted: Robert Shovlin to CEO from COO while remaining president; he replaces Vijay Aggarwal, who will remain a director WIR Staff Diagnostic...
BioCentury | Jul 24, 2008
Tools & Techniques

Imaging Prostate Cancer Metastasis

...gene in the presence of the prodrug ganciclovir. 3 Jason Alter, director of marketing at Aureon...
...for these patients. Although a ways away, imaging coupled with gene therapy has exciting potential." Aureon...
...recognizes PSMA, to image the extent and spread of prostate cancer. Companies and Institutions Mentioned Aureon...
BioCentury | Jun 16, 2008
Company News

Aureon Laboratories Inc., University of Texas M. D. Anderson Cancer Center deal

...discover biomarkers associated with disease progression and overall survival in non-small cell lung cancer (NSCLC). Aureon...
...from NSCLC patients for histological and molecular analysis. Further terms were not disclosed. Last month, Aureon...
...prostate cancer progression and disease recurrence at the time of diagnosis (see BioCentury, May 26). Aureon...
BioCentury | May 26, 2008
Company News

Aureon Biosciences Corp. sales and marketing update

...Px+ test to predict prostate cancer progression and disease recurrence at the time of diagnosis. Aureon...
BioCentury | Mar 24, 2008
Company News

Aureon Laboratories Inc. management update

Aureon Laboratories Inc. , Yonkers, N.Y. Business: Diagnostic, Pharmacogenetics Hired: Ana Stanic as CFO, formerly EVP and CFO of Omrix Biopharmaceuticals Inc. WIR Staff Diagnostic...
BioCentury | Jan 28, 2008
Company News

Aureon Laboratories Inc., Pfizer deal

...The companies will use Aureon's integrated systems pathology approach to establish quantitative biometrics for assessing prostate...
...work is an extension of a 2007 collaboration that demonstrated the technical feasibility of using Aureon's...
...the cellular distribution of cytokines in prosatectomy samples from patients treated with ADT from Pfizer. Aureon...
Items per page:
1 - 10 of 19